CLC Number:
| [1] McDonald JR, ODwyer ST, Renehan AG, et al. Classification of and cytoreductive surgery for lowgrade appendiceal mucinous neoplasms[J]. Br J Surg, 2012, 99(7): 987-992. [2] Renehan AG, O Dwyer ST, Stern PL. Pseudomyxoma peritonei[M] //. In: Schwab M, ed. Encyclopedia of Cancer.(London: Springer), 2008: 2134-2138. [3] Roberts DL, ODwyer ST, Stern PL, et al. Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines[J]. Oncotarget, 2015, 6(13): 10786-10800. [4] Joo MW, Chung YG, Hur SY, et al. Pseudomyxoma peritonei extending to the lower extremity: a case report[J]. World J Surg Oncol, 2015, 13:221. doi: 10.1186/s12957-015-0639-x. [5] Smeenk RM, Verwaal VJ, Antonini N, et al. Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome[J]. Ann Surg Oncol, 2007, 14(2): 493-499. [6] Chua TC, Liauw W, Morris DL. Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome[J]. Int J Colorectal Dis, 2012, 27(3): 381-389. [7] Yan TD, Black D, Savady R, et al. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei[J]. Ann Surg Oncol, 2007, 14(2): 484-492. [8] Chen YN, Lee JJ, Cheng SP, et al. Transformation of low-grade mucinous neoplasm of the appendix with pseudomyxoma peritonei to high-grade sarcomatoid carcinoma[J]. J Clin Med Res, 2015, 7(7): 571-574. [9] Kulu Y, Müller-Stich B, Büchler MW, et al. Surgical treatment of peritoneal carcinomatosis: current treatment modalities[J]. Langenbecks Arch Surg, 2014, 399(1): 41-53. [10] 吴婷婷,陈丁丁,陆建伟,等.雷替曲塞的临床应用[J].中国现代应用药学,2014,31(5): 643-646. [11] 张晶,钟武,李松. TNF-α抑制剂的研究进展[J].中国药物化学杂志,2010,20(4): 310-318. [12] van Horssen R, Ten Hagen TL, Eggermont AM.TNF-alpha in cancer treat-ment: molecular insights, antitumor effects, and clinical utility[J]. Oncologist, 2006, 11(4): 397-408. |
| [1] |
ZHANG Rui-yu, L Zhi-mei, LIU Yi, ZHANG Peng-ju, WAN Qiang, WANG Rong.
The mRNA-stabilizing factor Human-Antigen R regulates renal cyclinD1 post-transcriptional expression in human mesangial cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 47-52. |
|
||
